| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Cardlytics (NASDAQ:CDLX) sees Q4 sales of $86.000 million-$96.000 million vs $58.850 million analyst estimate.
Cardlytics (NASDAQ:CDLX) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.15) by...
Cardlytics Inc. (NASDAQ:CDLX) today announced an enterprise-wide cost savings initiative aimed at optimizing its cost structure...
Gainers GDEV (NASDAQ: GDEV) shares moved upwards by 24.5% to $25.45 during Friday's regular session. The company's mar...
Gainers Harrison Global Holdings (NASDAQ: BLMZ) stock moved upwards by 20.8% to $0.22 during Friday's pre-market session. ...
Cardlytics Inc. (NASDAQ: CDLX) saw its stock fall 9.85% during regular trading on Thursday. However, the stock rebounded in aft...
https://x.com/CitronResearch/status/1970897428589969832